tiprankstipranks
Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ
US Market
JAZZ
Jazz Pharmaceuticals
RESEARCH TOOLSreports

Jazz Pharmaceuticals (JAZZ) Stock News & Sentiment

1,877 Followers
3 Best Value Stocks with Over 10% Upside in 2026, According to Analysts 
Premium
Market News
3 Best Value Stocks with Over 10% Upside in 2026, According to Analysts 
26d ago
PCG
RCL
Jazz Pharmaceuticals Balances Record Gains With Slower 2026
Premium
Company Announcements
Jazz Pharmaceuticals Balances Record Gains With Slower 2026
1M ago
JAZZ
Jazz Pharmaceuticals Advances ONC206 Trial in Rare Tumors, Offering a New Pipeline Catalyst for JAZZ
Premium
Company Announcements
Jazz Pharmaceuticals Advances ONC206 Trial in Rare Tumors, Offering a New Pipeline Catalyst for JAZZ
1M ago
JAZZ
Jazz Pharmaceuticals: Underappreciated Growth Story with Durable Sleep Franchise and Pipeline-Driven Upside
Premium
Ratings
Jazz Pharmaceuticals: Underappreciated Growth Story with Durable Sleep Franchise and Pipeline-Driven Upside
1M ago
JAZZ
JAZZ Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
JAZZ Earnings this Week: How Will it Perform?
1M ago
JAZZ
Buy Rating on Jazz Pharmaceuticals Driven by Zanidatamab’s Differentiated Efficacy and Clear Regulatory Path in First-Line HER2+ GEA
Premium
Ratings
Buy Rating on Jazz Pharmaceuticals Driven by Zanidatamab’s Differentiated Efficacy and Clear Regulatory Path in First-Line HER2+ GEA
3M ago
JAZZ
Jazz Pharmaceuticals Completes Observational Study on Vyxeos Liposomal in AML Treatment
Premium
Company Announcements
Jazz Pharmaceuticals Completes Observational Study on Vyxeos Liposomal in AML Treatment
4M ago
JAZZ
More JAZZ News >

JAZZ News on the Web

Insider Sell: Bruce Cozadd Sells 6,000 Shares of Jazz Pharmaceuticals PLC (JAZZ)
GuruFocus News
Neutral
Why Is Keros Therapeutics (KROS) Up 2.5% Since Last Earnings Report?
Zacks
Neutral
Revolution Medicines (RVMD) Down 8.8% Since Last Earnings Report: Can It Rebound?
Zacks
Bullish
Why Is Jazz (JAZZ) Down 3.9% Since Last Earnings Report?
Zacks
Bullish
Piper Sandler Remains a Buy on Jazz Pharmaceuticals (JAZZ)
TipRanks News
Neutral
Jazz Pharmaceuticals price target raised to $232 from $219 at Piper Sandler
TipRanks News
Bullish
Jazz Pharmaceuticals to present clinical, preclinical data at AACR 2026
TipRanks News
Bullish
Zymework’ partner Jazz to present on Ziihera at 2026 AACR Annual Meeting
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
JAZZ
Sector Average
Media Buzz
This Week2 articles
Weekly Average3.75 articles
News Sentiment
This Week50%
Sector Average64%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JAZZ’s Media Buzz Sentiment?
2 articles about JAZZ were published this week. In an average week, 3.75 articles are published.
    What is JAZZ’s weekly average amount of articles?
    In an average week, 3.75 articles about JAZZ are published.
      What is JAZZ’s News Sentiment?
      50% of articles about JAZZ were positive this week, compared to its sector average of 64%.
        Healthcare Stocks that are Trending in the News
        OMEROmeros
        AGIOAgios Pharma
        PALIPalisade Bio
        LTRNLantern Pharma
        CNTBConnect Biopharma Holdings
        Showing the stocks with the most bullish news sentiment over the past week